Dietary fiber treatment corrects the composition of gut microbiota, promotes SCFA production, and suppresses colon carcinogenesis

Genes

Volumn 9, Issue 2, 2018, Pages

  Bishehsari, Faraz ^a   Engen, Phillip A ^a   Preite, Nailliw Z ^a   Tuncil, Yunus E ^b,f   Naqib, Ankur ^c   Shaikh, Maliha ^a   Rossi, Marco ^a   Wilber, Sherry ^a   Green, Stefan J ^c   Hamaker, Bruce R ^b   Khazaie, Khashayarsha ^d   Voigt, Robin M ^a   Forsyth, Christopher B ^a   Keshavarzian, Ali ^a,e  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b PURDUE UNIVERSITY   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d MAYO GRADUATE SCHOOL   (United States)

^e UTRECHT UNIVERSITY   (Netherlands)

^f ORDU UNIVERSITY   (Turkey)

Author keywords

Butyrate; CRC; Dietary fiber; Microbiota; SCFA

Indexed keywords

SHORT CHAIN FATTY ACID;

ACTINOBACTERIA; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIFIDOBACTERIUM; COLON CARCINOGENESIS; CONTROLLED STUDY; DIETARY FIBER; DIETARY INTAKE; FECES ANALYSIS; FECES MICROFLORA; HIGH FIBER DIET; HISTONE ACETYLATION; INTESTINE FLORA; LACHNOSPIRACEAE; LACTOBACILLUS; MALE; MOUSE; MYCOPLASMATACEAE; NONHUMAN; POLYPOSIS; PREVOTELLA;

EID: 85042366667     PISSN: None     EISSN: 20734425     Source Type: Journal    
DOI: 10.3390/genes9020102     Document Type: Article

References (85)

1. World Cancer Research Fund/American Institute for Cancer Research. Policy and Action for Cancer Prevention. Food, Nutrition, and Physical Activity: A Global Perspective. AICR: Washington DC, 2009; p. 201. Available online: http://www.wcrf-hk.org/sites/default/files/Policy_Report.pdf
2. American Cancer Society. Cancer facts & figures 2012. ACS: Atlanta, 2012; p. 68. Available online: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2012/cancer-facts-and-figures-2012.pdf
3. Kunzmann, A.T.; Coleman, H.G.; Huang, W.Y.; Kitahara, C.M.; Cantwell, M.M.; Berndt, S.I. Dietary fiber intake and risk of colorectal cancer and incident and recurrent adenoma in the prostate, lung, colorectal, and ovarian cancer screening trial. Am. J. Clin. Nutr. 2015, 102, 881–890. doi:10.3945/ajcn.115.113282.
4. Murphy, N.; Norat, T.; Ferrari, P.; Jenab, M.; Bueno-de-Mesquita, B.; Skeie, G.; Dahm, C.C.; Overvad, K.; Olsen, A.; Tjonneland, A., et al. Dietary fibre intake and risks of cancers of the colon and rectum in the european prospective investigation into cancer and nutrition (epic). PLoS One 2012, 7, e39361. doi:10.1371/journal.pone.0039361.
5. OʹKeefe, S.J. Diet, microorganisms and their metabolites, and colon cancer. Nat. Rev. Gastroenterol. Hepatol. 2016, 13, 691–706. doi:10.1038/nrgastro.2016.165.
6. Ganapathy, V.; Thangaraju, M.; Prasad, P.D.; Martin, P.M.; Singh, N. Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host. Curr. Opin. Pharmacol. 2013, 13, 869–874. doi:10.1016/j.coph.2013.08.006.
7. Sobhani, I.; Tap, J.; Roudot-Thoraval, F.; Roperch, J.P.; Letulle, S.; Langella, P.; Corthier, G.; Tran Van Nhieu, J.; Furet, J.P. Microbial dysbiosis in colorectal cancer (crc) patients. PLoS One 2011, 6, e16393. doi:10.1371/journal.pone.0016393.
8. Gao, R.; Kong, C.; Li, H.; Huang, L.; Qu, X.; Qin, N.; Qin, H. Dysbiosis signature of mycobiota in colon polyp and colorectal cancer. Eur. J. Clin. Microbiol. Infect. Dis. 2017, 36, 2457–2468. doi:10.1007/s10096–017–3085–6.
9. Yao, Y.; Suo, T.; Andersson, R.; Cao, Y.; Wang, C.; Lu, J.; Chui, E. Dietary fibre for the prevention of recurrent colorectal adenomas and carcinomas. Cochrane Database Syst. Rev. 2017, 1, CD003430. doi:10.1002/14651858.CD003430.pub2.
10. Bultman, S.J. Interplay between diet, gut microbiota, epigenetic events, and colorectal cancer. Mol. Nutr. Food Res. 2017, 61. doi:10.1002/mnfr.201500902.
11. Roller, M.; Clune, Y.; Collins, K.; Rechkemmer, G.; Watzl, B. Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics lactobacillus rhamnosus and bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients. Br. J. Nutr. 2007, 97, 676–684. doi:10.1017/S0007114507450292.
12. Corpet, D.E.; Pierre, F. How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men. Eur. J. Cancer 2005, 41, 1911–1922. doi:10.1016/j.ejca.2005.06.006.
13. Mai, V.; Colbert, L.H.; Perkins, S.N.; Schatzkin, A.; Hursting, S.D. Intestinal microbiota: A potential diet-responsive prevention target in apcmin mice. Mol. Carcinog. 2007, 46, 42–48. doi:10.1002/mc.20233.
14. Zackular, J.P.; Baxter, N.T.; Iverson, K.D.; Sadler, W.D.; Petrosino, J.F.; Chen, G.Y.; Schloss, P.D. The gut microbiome modulates colon tumorigenesis. M. Bio. 2013, 4, e00692–00613. doi:10.1128/mBio.00692–13.
15. Hamaker, B.R.; Tuncil, Y.E. A perspective on the complexity of dietary fiber structures and their potential effect on the gut microbiota. J. Mol. Biol. 2014, 426, 3838–3850. doi:10.1016/j.jmb.2014.07.028.
16. Saam, J.R.; Gordon, J.I. Inducible gene knockouts in the small intestinal and colonic epithelium. J. Biol. Chem 1999, 274, 38071–38082.
17. Khazaie, K.; Zadeh, M.; Khan, M.W.; Bere, P.; Gounari, F.; Dennis, K.; Blatner, N.R.; Owen, J.L.; Klaenhammer, T.R.; Mohamadzadeh, M. Abating colon cancer polyposis by lactobacillus acidophilus deficient in lipoteichoic acid. Proc. Natl. Acad. Sci. USA 2012, 109, 10462–10467. doi:10.1073/pnas.1207230109.
18. Gounaris, E.; Erdman, S.E.; Restaino, C.; Gurish, M.F.; Friend, D.S.; Gounari, F.; Lee, D.M.; Zhang, G.; Glickman, J.N.; Shin, K.; et al. Mast cells are an essential hematopoietic component for polyp development. Proc. Natl. Acad. Sci. USA 2007, 104, 19977–19982. doi:10.1073/pnas.0704620104.
19. Fischer, A.H.; Jacobson, K.A.; Rose, J.; Zeller, R. Hematoxylin and eosin staining of tissue and cell sections. CSH Protoc. 2008, 2008, pdb prot4986. doi:10.1101/pdb.prot4986.
20. Forsyth, C.B.; Pulai, J.; Loeser, R.F. Fibronectin fragments and blocking antibodies to alpha2beta1 and alpha5beta1 integrins stimulate mitogen-activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes. Arthritis Rheum. 2002, 46, 2368– 2376. doi:10.1002/art.10502.
21. Banan, A.; Zhang, L.J.; Shaikh, M.; Fields, J.Z.; Choudhary, S.; Forsyth, C.B.; Farhadi, A.; Keshavarzian, A. Theta isoform of protein kinase c alters barrier function in intestinal epithelium through modulation of distinct claudin isotypes: A novel mechanism for regulation of permeability. J. Pharmacol. Exp. Ther. 2005, 313, 962–982. doi:10.1124/jpet.104.083428.
22. Bishehsari, F.; Saadalla, A.; Khazaie, K.; Engen, P.A.; Voigt, R.M.; Shetuni, B.B.; Forsyth, C.; Shaikh, M.; Vitaterna, M.H.; Turek, F.; et al. Light/dark shifting promotes alcohol-induced colon carcinogenesis: Possible role of intestinal inflammatory milieu and microbiota. Int. J. Mol. Sci. 2016, 17. doi:10.3390/ijms17122017.
23. Schmieder, R.; Edwards, R. Quality control and preprocessing of metagenomic datasets. Bioinformatics 2011, 27, 863–864. doi:10.1093/bioinformatics/btr026.
24. Edgar, R.C. Search and clustering orders of magnitude faster than blast. Bioinformatics 2010, 26, 2460–2461. doi:10.1093/bioinformatics/btq461.
25. Caporaso, J.G.; Kuczynski, J.; Stombaugh, J.; Bittinger, K.; Bushman, F.D.; Costello, E.K.; Fierer, N.; Pena, A.G.; Goodrich, J.K.; Gordon, J.I.; et al. Qiime allows analysis of high-throughput community sequencing data. Nat. Methods 2010, 7, 335–336. doi:10.1038/nmeth.f.303.
26. McDonald, D.; Clemente, J.C.; Kuczynski, J.; Rideout, J.R.; Stombaugh, J.; Wendel, D.; Wilke, A.; Huse, S.; Hufnagle, J.; Meyer, F.; et al. The biological observation matrix (BIOM) format or: How I learned to stop worrying and love the ome-ome. Gigascience 2012, 1, 7. doi:10.1186/2047–217X-1–7.
27. Clarke, K.R. Non-parametric multivariate analyses of changes in community structure. Australian Journal of Ecology 1993, 18, 117–143. doi:10.1111/j.1442–9993.1993.tb00438.x.
28. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2013. Available online: http://www.R-project.org/.
29. Oksanen, J.; Blanchet, F.G.; Friendly, M.; Kindt, R.; Legendre, P.; McGlinn, D.; Minchin, P.R.; OʹHara, R.B.; Simpson, G.L.; Solymos, P., et al. Package ʹveganʹ. Community ecology package. 2 ed. ed.; 2016.
30. Langille, M.G.; Zaneveld, J.; Caporaso, J.G.; McDonald, D.; Knights, D.; Reyes, J.A.; Clemente, J.C.; Burkepile, D.E.; Vega Thurber, R.L.; Knight, R.; et al. Predictive functional profiling of microbial communities using 16s rrna marker gene sequences. Nat. Biotechnol. 2013, 31, 814–821. doi:10.1038/nbt.2676.
31. Kanehisa, M.; Goto, S. Kegg: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000, 28, 27–30.
32. Canani, R.B.; Costanzo, M.D.; Leone, L.; Pedata, M.; Meli, R.; Calignano, A. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J. Gastroenterol. 2011, 17, 1519–1528. doi:10.3748/wjg.v17.i12. 1519.
33. Louis, P.; Flint, H.J. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol. Lett. 2009, 294, 1–8. doi:10.1111/j.1574–6968.2009.01514.x.
34. Macfarlane, S.; Macfarlane, G.T. Regulation of short-chain fatty acid production. Proc. Nutr. Soc. 2003, 62, 67–72. doi:10.1079/PNS2002207.
35. Hakansson, A.; Molin, G. Gut microbiota and inflammation. Nutrients 2011, 3, 637–682. doi:10.3390/nu3060637.
36. Wexler, H.M. Bacteroides: The good, the bad, and the nittygritty. Clin. Microbiol. Rev. 2007, 20, 593–621. doi:10.1128/CMR.00008–07.
37. Rajilic-Stojanovic, M.; de Vos, W.M. The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol. Rev. 2014, 38, 996–1047. doi:10.1111/1574–6976.12075.
38. Louis, P.; Hold, G.L.; Flint, H.J. The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 2014, 12, 661–672. doi:10.1038/nrmicro3344.
39. Riviere, A.; Selak, M.; Lantin, D.; Leroy, F.; De Vuyst, L. Bifidobacteria and butyrate-producing colon bacteria: Importance and strategies for their stimulation in the human gut. Front. Microbiol. 2016, 7, 979. doi:10.3389/fmicb.2016.00979.
40. Reichardt, N.; Duncan, S.H.; Young, P.; Belenguer, A.; McWilliam Leitch, C.; Scott, K.P.; Flint, H.J.; Louis, P. Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. ISME J. 2014, 8, 1323–1335. doi:10.1038/ismej.2014.14.
41. Li, J.; Zhao, F.; Wang, Y.; Chen, J.; Tao, J.; Tian, G.; Wu, S.; Liu, W.; Cui, Q.; Geng, B., et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome 2017, 5, 14. doi:10.1186/s40168–016– 0222-x.
42. Louis, P.; Flint, H.J. Formation of propionate and butyrate by the human colonic microbiota. Environ. Microbiol. 2017, 19, 29–41. doi:10.1111/1462–2920.13589.
43. Antharam, V.C.; Li, E.C.; Ishmael, A.; Sharma, A.; Mai, V.; Rand, K.H.; Wang, G.P. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea. J. Clin. Microbiol. 2013, 51, 2884–2892. doi:10.1128/JCM.00845–13.
44. Tuncil, Y.E.; Nakatsu, C.H.; Kazem, A.E.; AriogluTuncil, S.; Reuhs, B.; Martens, E.C.; Hamaker, B.R. Delayed utilization of some fast-fermenting soluble dietary fibers by human gut microbiota when presented in a mixture. Journal of Functional Foods 2017, 32, 347–357. doi:https://doi.org/10.1016/j.jff.2017.03.001
45. Flemer, B.; Gaci, N.; Borrel, G.; Sanderson, I.R.; Chaudhary, P.P.; Tottey, W.; OʹToole, P.W.; Brugere, J.F. Fecal microbiota variation across the lifespan of the healthy laboratory rat. Gut Microbes 2017, 8, 428–439. doi:10.1080/19490976.2017.1334033.
46. Earley, H.; Lennon, G.; Balfe, A.; Kilcoyne, M.; Clyne, M.; Joshi, L.; Carrington, S.; Martin, S.T.; Coffey, J.C.; Winter, D.C.; et al. A preliminary study examining the binding capacity of Akkermansia muciniphila and Desulfovibrio spp., to colonic mucin in health and ulcerative colitis. PLoS One 2015, 10, e0135280. doi:10.1371/journal.pone.0135280.
47. Puppa, M.J.; White, J.P.; Sato, S.; Cairns, M.; Baynes, J.W.; Carson, J.A. Gut barrier dysfunction in the apc(min/+) mouse model of colon cancer cachexia. Biochim. Biophys. Acta 2011, 1812, 1601–1606. doi:10.1016/j.bbadis.2011.08.010.
48. Zhu, Q.; Jin, Z.; Wu, W.; Gao, R.; Guo, B.; Gao, Z.; Yang, Y.; Qin, H. Analysis of the intestinal lumen microbiota in an animal model of colorectal cancer. PLoS One 2014, 9, e90849. doi:10.1371/journal.pone.0090849.
49. Mariat, D.; Firmesse, O.; Levenez, F.; Guimaraes, V.; Sokol, H.; Dore, J.; Corthier, G.; Furet, J.P. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 2009, 9, 123. doi:10.1186/1471–2180–9-123.
50. Voreades, N.; Kozil, A.; Weir, T.L. Diet and the development of the human intestinal microbiome. Front. Microbiol. 2014, 5, 494. doi:10.3389/fmicb.2014.00494.
51. Min/+ mice. J Appl. Microbiol. 2017, 122, 770–784. doi:10.1111/jam.13386.
52. Sugawara, T.; Miyazawa, T. Beneficial effect of dietary wheat glycolipids on cecum short-chain fatty acid and secondary bile acid profiles in mice. J. Nutr. Sci. Vitaminol. (Tokyo) 2001, 47, 299–305.
53. Zhu, Q.; Gao, R.; Wu, W.; Qin, H. The role of gut microbiota in the pathogenesis of colorectal cancer. Tumour. Biol. 2013, 34, 1285–1300. doi:10.1007/s13277–013–0684–4.
54. Hold, G.L.; Smith, M.; Grange, C.; Watt, E.R.; El-Omar, E.M.; Mukhopadhya, I. Role of the gut microbiota in inflammatory bowel disease pathogenesis: What have we learnt in the past 10 years? World J. Gastroenterol. 2014, 20, 1192–1210. doi:10.3748/wjg.v20.i5.1192.
55. Cammarota, G.; Ianiro, G.; Cianci, R.; Bibbo, S.; Gasbarrini, A.; Curro, D. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy. Pharmacol. Ther. 2015, 149, 191–212. doi:10.1016/j.pharmthera.2014.12.006.
56. Power, K.A.; Lepp, D.; Zarepoor, L.; Monk, J.M.; Wu, W.; Tsao, R.; Liu, R. Dietary flaxseed modulates the colonic microenvironment in healthy C57BL/6 male mice which may alter susceptibility to gut-associated diseases. J. Nutr. Biochem. 2016, 28, 61–69. doi:10.1016/j.jnutbio.2015.09.028.
57. Zhao, Y.; Wu, J.; Li, J.V.; Zhou, N.Y.; Tang, H.; Wang, Y. Gut microbiota composition modifies fecal metabolic profiles in mice. J. Proteome. Res. 2013, 12, 2987–2999. doi:10.1021/pr400263n.
58. Ericsson, A.C.; Akter, S.; Hanson, M.M.; Busi, S.B.; Parker, T.W.; Schehr, R.J.; Hankins, M.A.; Ahner, C.E.; Davis, J.W.; Franklin, C.L.; et al. Differential susceptibility to colorectal cancer due to naturally occurring gut microbiota. Oncotarget 2015, 6, 33689–33704. doi:10.18632/oncotarget.5604.
59. Hinnebusch, B.F.; Meng, S.; Wu, J.T.; Archer, S.Y.; Hodin, R.A. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J. Nutr. 2002, 132, 1012–1017.
60. Kiefer, J.; Beyer-Sehlmeyer, G.; Pool-Zobel, B.L. Mixtures of SCFA, composed according to physiologically available concentrations in the gut lumen, modulate histone acetylation in human HT29 colon cancer cells. Br. J. Nutr. 2006, 96, 803–810.
61. Forest, V.; Clement, M.; Pierre, F.; Meflah, K.; Menanteau, J. Butyrate restores motile function and actin cytoskeletal network integrity in apc mutated mouse colon epithelial cells. Nutr. Cancer 2003, 45, 84–92. doi:10.1207/S15327914NC4501_10.
62. Hamer, H.M.; Jonkers, D.M.; Bast, A.; Vanhoutvin, S.A.; Fischer, M.A.; Kodde, A.; Troost, F.J.; Venema, K.; Brummer, R.J. Butyrate modulates oxidative stress in the colonic mucosa of healthy humans. Clin. Nutr. 2009, 28, 88–93. doi:10.1016/j.clnu.2008.11.002.
63. Leonel, A.J.; Alvarez-Leite, J.I. Butyrate: Implications for intestinal function. Curr. Opin. Clin. Nutr. Metab. Care. 2012, 15, 474–479. doi:10.1097/MCO.0b013e32835665fa.
64. Thangaraju, M.; Cresci, G.A.; Liu, K.; Ananth, S.; Gnanaprakasam, J.P.; Browning, D.D.; Mellinger, J.D.; Smith, S.B.; Digby, G.J.; Lambert, N.A.; et al. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res. 2009, 69, 2826– 2832. doi:10.1158/0008–5472.can-08–4466.
65. Singh, N.; Gurav, A.; Sivaprakasam, S.; Brady, E.; Padia, R.; Shi, H.; Thangaraju, M.; Prasad, P.D.; Manicassamy, S.; Munn, D.H.; et al. Activation of GPR19A, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 2014, 40, 128–139. doi:10.1016/j.immuni.2013.12.007.
66. Consortium, H.M.P. Structure, function and diversity of the healthy human microbiome. Nature 2012, 486, 207–214. doi:10.1038/nature11234.
67. Shen, X.J.; Rawls, J.F.; Randall, T.; Burcal, L.; Mpande, C.N.; Jenkins, N.; Jovov, B.; Abdo, Z.; Sandler, R.S.; Keku, T.O. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes 2010, 1, 138–147. doi:10.4161/gmic.1.3.12360.
68. Flemer, B.; Lynch, D.B.; Brown, J.M.; Jeffery, I.B.; Ryan, F.J.; Claesson, M.J.; OʹRiordain, M.; Shanahan, F.; OʹToole, P.W. Tumour-associated and non-tumour-associated microbiota in colorectal cancer. Gut 2017, 66, 633–643. doi:10.1136/gutjnl-2015–309595.
69. Purcell, R.V.; Pearson, J.; Aitchison, A.; Dixon, L.; Frizelle, F.A.; Keenan, J.I. Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia. PLoS One 2017, 12, e0171602. doi:10.1371/journal.pone.0171602.
70. Moen, B.; Henjum, K.; Mage, I.; Knutsen, S.H.; Rud, I.; Hetland, R.B.; Paulsen, J.E. Effect of dietary fibers on cecal microbiota and intestinal tumorigenesis in azoxymethane treated A/J Min/+ mice. PLoS One 2016, 11, e0155402. doi:10.1371/journal.pone.0155402.
71. Yang, Y.; Jobin, C. Microbial imbalance and intestinal pathologies: Connections and contributions. Dis. Model. Mech. 2014, 7, 1131–1142. doi:10.1242/dmm.016428.
72. Borges-Canha, M.; Portela-Cidade, J.P.; Dinis-Ribeiro, M.; Leite-Moreira, A.F.; Pimentel-Nunes, P. Role of colonic microbiota in colorectal carcinogenesis: A systematic review. Rev. Esp. Enferm. Dig. 2015, 107, 659– 671. doi:10.17235/reed.2015.3830/2015.
73. Fukuda, S.; Toh, H.; Hase, K.; Oshima, K.; Nakanishi, Y.; Yoshimura, K.; Tobe, T.; Clarke, J.M.; Topping, D.L.; Suzuki, T., et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011, 469, 543–547. doi:10.1038/nature09646.
74. Belenguer, A.; Holtrop, G.; Duncan, S.H.; Anderson, S.E.; Calder, A.G.; Flint, H.J.; Lobley, G.E. Rates of production and utilization of lactate by microbial communities from the human colon. FEMS Microbiol. Ecol. 2011, 77, 107–119. doi:10.1111/j.1574–6941.2011.01086.x.
75. You, H.J.; Oh, D.K.; Ji, G.E. Anticancerogenic effect of a novel chiroinositol-containing polysaccharide from Bifidobacterium bifidum BGN4. FEMS Microbiol. Lett. 2004, 240, 131–136. doi:10.1016/j.femsle.2004.09.020.
76. Tirandaz, H.; Mohammadi, E. Efficient tumor targeting by anaerobic butyrate-producing bacteria. Med. Hypotheses 2013, 80, 675–678. doi:10.1016/j.mehy.2013.01.024.
77. Velasquez-Manoff, M. Gut microbiome: The peacekeepers. Nature 2015, 518, S3–11. doi:10.1038/518S3a.
78. OʹKeefe, S.J.; Ou, J.; Aufreiter, S.; OʹConnor, D.; Sharma, S.; Sepulveda, J.; Fukuwatari, T.; Shibata, K.; Mawhinney, T. Products of the colonic microbiota mediate the effects of diet on colon cancer risk. J. Nutr. 2009, 139, 2044–2048. doi:10.3945/jn.109.104380.
79. O’Keefe, S.J.; Li, J.V.; Lahti, L.; Ou, J.; Carbonero, F.; Mohammed, K.; Posma, J.M.; Kinross, J.; Wahl, E.; Ruder, E., et al. Fat, fibre and cancer risk in African Americans and rural Africans. Nat. Commun. 2015, 6, 6342. doi:10.1038/ncomms7342.
80. Ohkawara, S.; Furuya, H.; Nagashima, K.; Asanuma, N.; Hino, T. Oral administration of butyrivibrio fibrisolvens, a butyrate-producing bacterium, decreases the formation of aberrant crypt foci in the colon and rectum of mice. J. Nutr. 2005, 135, 2878–2883.
81. Davie, J.R. Inhibition of histone deacetylase activity by butyrate. J. Nutr. 2003, 133, 2485S-2493S.
82. Bardhan, K.; Paschall, A.V.; Yang, D.; Chen, M.R.; Simon, P.S.; Bhutia, Y.D.; Martin, P.M.; Thangaraju, M.; Browning, D.D.; Ganapathy, V.; et al. IFNγ induces DNA methylation-silenced GPR109A expression via pSTAT1/p300 and H3K18 acetylation in colon cancer. Cancer Immunol. Res. 2015, 3, 795–805. doi:10.1158/2326–6066.CIR-14–0164.
83. Higashimura, Y.; Naito, Y.; Takagi, T.; Uchiyama, K.; Mizushima, K.; Ushiroda, C.; Ohnogi, H.; Kudo, Y.; Yasui, M.; Inui, S.; et al. Protective effect of agaro-oligosaccharides on gut dysbiosis and colon tumorigenesis in high-fat diet-fed mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2016, 310, G367–375. doi:10.1152/ajpgi.00324.2015.
84. Donohoe, D.R.; Holley, D.; Collins, L.B.; Montgomery, S.A.; Whitmore, A.C.; Hillhouse, A.; Curry, K.P.; Renner, S.W.; Greenwalt, A.; Ryan, E.P.; et al. A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner. Cancer Discov. 2014, 4, 1387–1397. doi:10.1158/2159–8290.CD-14–0501.
85. Mehta, R.S.; Nishihara, R.; Cao, Y.; Song, M.; Mima, K.; Qian, Z.R.; Nowak, J.A.; Kosumi, K.; Hamada, T.; Masugi, Y.; et al. Association of dietary patterns with risk of colorectal cancer subtypes classified by fusobacterium nucleatum in tumor tissue. JAMA Oncol. 2017, 3, 921–927. doi:10.1001/jamaoncol.2016.6374.